Alpine 4 Holdings subsidiary Alternative Laboratories adds $2M in backlog nutritionals orders

Alpine 4 Holdings Inc (OTCQB:ALPP) announced that its subsidiary, Alternative Laboratories LLC, has secured new production orders worth $2 million to be completed in June and July.

The new projects bring Alt Labs’ backlog total to $5.8 million in production work. The company working on around 40 new formulas and is in the process of expanding its R&D staff to keep up with the influx. Additionally, with the addition of a second 800kg double cone blender, Alt Labs has more than enough capacity to accommodate its current and new clientele, the company said. 

“With the addition of our new mixing equipment, investments in training, and other capital initiatives, 2021 is already shaping up to be better than 2020,” Alt Labs COO Mark Wesolaski said in a statement. “The company is on track to produce well over $22 million for 2021.”

READ: Alpine 4 Holdings is undergoing a ‘metamorphosis,’ CEO Kent Wilson writes in letter to shareholders

Alt Labs, a private label contract manufacturer located in Florida, specializes in the manufacturing and packaging of liquids, powders, tablets, capsules and other unique nutritionals. The company has a wide array of customers that sell their products in the US and internationally through ecommerce platforms like Amazon, as well as direct business to consumer.

“It’s always a pleasure to see a newly added subsidiary firing on all cylinders this quickly after being acquired,” Alpine 4 CEO Kent Wilson said in a statement. “These orders add to an already impressive backlog of work for 2021.”

Alpine 4 Holdings is a conglomerate that acquires businesses that fit into its disruptive DSF business model of drivers, stabilizers, and facilitators. The company’s focus is on how the adaptation of new technologies, even in brick-and-mortar businesses, can drive innovation.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors